Are you checking for any specific mutations in NSCLC that suggest resistance to checkpoint inhibitors?

There has been a significant amount of data both published and presented concerning the various genomic markers (mutations) that may predict for response or the absence of response to immune checkpoint inhibitor. However, in clinical practice they are not commonly used as most patients are receiving...